What is CHITOSE Group?
Operating as a sophisticated family of biotechnology enterprises, CHITOSE Group is dedicated to the long-term objective of fostering an abundant society through the mastery of biological systems. The company distinguishes itself by integrating rigorous technological development with a pragmatic business development framework, ensuring that scientific breakthroughs are not merely theoretical but are economically rational and scalable. By collaborating with a global network of partners, CHITOSE Group addresses critical challenges in food security, medical advancement, energy production, and chemical synthesis, effectively positioning itself as a leader in the transition toward a bio-based industrial paradigm.
How much funding has CHITOSE Group raised?
CHITOSE Group has raised a total of $6.2M across 1 funding round:
Other Financing Round
$6.2M
Other Financing Round (2024): $6.2M with participation from SMBC Group
Key Investors in CHITOSE Group
SMBC Group
SMBC Group is a premier global financial institution providing comprehensive banking and investment solutions, with a strategic focus on supporting large-scale industrial innovation and sustainable economic growth.
What's next for CHITOSE Group?
The infusion of capital from this recent financing round provides the necessary runway for CHITOSE Group to deepen its commitment to the global bioeconomy. Strategic priorities moving forward include the expansion of its proprietary technology platforms and the intensification of commercialization efforts for its diverse product pipeline. By leveraging its unique dual-competency model—combining deep scientific expertise with market-driven business development—the group is poised to capture significant market share in the emerging bio-manufacturing sector. Investors and industry observers will be monitoring the firm's ability to translate this latest investment into tangible, large-scale industrial outcomes that redefine the boundaries of sustainable biotechnology.
See full CHITOSE Group company page
